Omeprazole 1 In 1 Blister Pack | Cardinal Health while Breastfeeding
There are high number of clear evidence that breastfeeding provides best nutrition that you can give to your baby. It is also evident that lactation is good for mothers health as well. Evolution has designed breastfeeding in a way that it caters all nutritional need of your child. However modern medicine is quite new for evolution, that is why mothers body is not well prepared to filter unnecessary chemical found in medicines. It becomes a necessity to figure out which drug is safe and which drug is dangerous for your newborn while nursing. In this article we will understand function of Omeprazole 1 In 1 Blister Pack | Cardinal Health and its suitability with breastfeeding.

What is Omeprazole 1 In 1 Blister Pack | Cardinal Health used for?


Omeprazole is a proton pump inhibitor indicated for: •Treatment in adults of duodenal ulcer ( 1.1) and gastric ulcer ( 1.2) •Treatment in adults and children of gastroesophageal reflux disease (GERD) ( 1.3) and maintenance of healing of erosive esophagitis ( 1.4) •Pathologic Hypersecretory Conditions ( 1.5) The safety and effectiveness of omeprazole in pediatric patients < 1 year of age have not been established. ( 8.4) 1.1 Duodenal Ulcer (adults) Omeprazole delayed-release capsules are indicated for short-term treatment of active duodenal ulcer in adults. Most patients heal within 4 weeks. Some patients may require an additional 4 weeks of therapy. Omeprazole delayed-release capsules, in combination with clarithromycin and amoxicillin, are indicated for treatment of patients with H. pylori infection and duodenal ulcer disease (active or up to one year history) to eradicate H. pylori in adults. Omeprazole delayed-release capsules, in combination with clarithromycin are indicated for treatment of patients with H. pylori infection and duodenal ulcer disease to eradicate H. pylori in adults. Eradication of H. pylori has been shown to reduce the risk of duodenal ulcer recurrence [see Clinical Studies (14.1) and Dosage and Administration (2)]. Among patients who fail therapy, omeprazole delayed-release capsules with clarithromycin are more likely to be associated with the development of clarithromycin resistance as compared with triple therapy. In patients who fail therapy, susceptibility testing should be done. If resistance to clarithromycin is demonstrated or susceptibility testing is not possible, alternative antimicrobial therapy should be instituted [see Microbiology section (12.4)] and the clarithromycin package insert, Microbiology section . 1.2 Gastric Ulcer (adults) Omeprazole delayed-release capsules are indicated for short-term treatment (4 to 8 weeks) of active benign gastric ulcer in adults [see Clinical Studies (14.2)]. 1.3 Treatment of Gastroesophageal Reflux Disease (GERD) (adults and pediatric patients) Symptomatic GERD Omeprazole delayed-release capsules are indicated for the treatment of heartburn and other symptoms associated with GERD in pediatric patients and adults for up to 4 weeks. Erosive Esophagitis Omeprazole delayed-release capsules are indicated for the short-term treatment (4 to 8 weeks) of erosive esophagitis that has been diagnosed by endoscopy in pediatric patients and adults [see Clinical Studies (14.4)]. The efficacy of omeprazole delayed-release capsules used for longer than 8 weeks in these patients has not been established. If a patient does not respond to 8 weeks of treatment, an additional 4 weeks of treatment may be given. If there is recurrence of erosive esophagitis or GERD symptoms (e.g., heartburn), additional 4 to 8 week courses of omeprazole may be considered. 1.4 Maintenance of Healing of Erosive Esophagitis (adults and pediatric patients) Omeprazole delayed-release capsules are indicated to maintain healing of erosive esophagitis in pediatric patients and adults. Controlled studies do not extend beyond 12 months [see Clinical Studies (14.4)]. 1.5 Pathological Hypersecretory Conditions (adults) Omeprazole delayed-release capsules are indicated for the long-term treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome, multiple endocrine adenomas and systemic mastocytosis) in adults.

Is using Omeprazole 1 In 1 Blister Pack | Cardinal Health unsafe in breastfeeding? Can there be bad consequences for baby if I use it while breastfeeding?

Omeprazole 1 In 1 Blister Pack | Cardinal Health safe for breastfeeding
As per our analysis Omeprazole 1 In 1 Blister Pack | Cardinal Health contains only one ingredient and that is Omeprazole. We have analyzed Omeprazole and it seems to be safe to use Omeprazole while breastfeeding, that means usage of Omeprazole 1 In 1 Blister Pack | Cardinal Health shall be safe while breastfeeding. Below you can check more details of Omeprazole usage in breastfeeding. We recommend you to go through provided detailed analysis as below take decision accordingly.

Statement of Manufacturer/Labeler about breastfeeding usage
8.3 Nursing Mothers Omeprazole is present in human milk. Omeprazole concentrations were measured in breast milk of a woman following oral administration of 20 mg. The peak concentration of omeprazole in breast milk was less than 7% of the peak serum concentration. This concentration would correspond to 0.004 mg of omeprazole in 200 mL of milk. Caution should be exercised when omeprazole is administered to a nursing woman.

Omeprazole 1 In 1 Blister Pack | Cardinal Health Breastfeeding Analsys


Omeprazole while Breastfeeding

Safe

CAS Number: 73590-58-6

High plasma protein binding makes excretion into breast milk to be insignificant. No side effects were observed in breastfed infants of treated mothers. Shown to be labile in acid-pH environment must be administered in the form of micro-granules within an enteric-coated capsule. Any small quantity reaching the infant's stomach would be readily inactivated. Hyperprolactinemia and Galactorrhea have been reported.


Omeprazole 1 In 1 Blister Pack | Cardinal Health Breastfeeding Analsys - 2


Omeprazole while Breastfeeding

CAS Number: 73590-58-6

Limited information indicates that maternal omeprazole doses of 20 mg daily produce low levels in milk and would not be expected to cause any adverse effects in breastfed infants.


Omeprazole 1 In 1 Blister Pack | Cardinal Health and breastfeeding

What should I do if I am breastfeeding mother and I am already exposed to Omeprazole 1 In 1 Blister Pack | Cardinal Health?

As usage of Omeprazole 1 In 1 Blister Pack | Cardinal Health is mostly safe while breastfeeding hence there should not be any concern. In case of any change in behavior or health of your baby you should inform your health care provider about usage of Omeprazole 1 In 1 Blister Pack | Cardinal Health else no further action is required.


My health care provider has asked me to use Omeprazole 1 In 1 Blister Pack | Cardinal Health, what to do?

Usage of Omeprazole 1 In 1 Blister Pack | Cardinal Health is safe for nursing mothers and baby, No worries.


If I am using Omeprazole 1 In 1 Blister Pack | Cardinal Health, will my baby need extra monitoring?

No


Who can I talk to if I have questions about usage of Omeprazole 1 In 1 Blister Pack | Cardinal Health in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week